Home › Drug Codes › J Codes › J9201 · GEMCITABINE
Updated July 1st, 2026

GEMCITABINE J Code: J9201

Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J9201, effective October 1, 2026: $2.734 per HCPCS billing unit, down 5.2% from $2.884. From CMS's final file.

?
Medicare Payment Limit ?
$2.884
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
51
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
HCPCS Added Date January 1, 1998
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection | Injection, Powder, Lyophilized, For Solution | Injection, Solution | Not Available

About GEMCITABINE

Gemcitabine is a medication aligned to the HCPCS J Code: J9201 for billing, pricing, and reimbursement purposes in the United States. This Oncology medication is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: Gemcitabine is used to treat certain types of cancer (including biliary tract, breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 51 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9340-01 Gemcitabine Hikma Pharmaceuticals USA Inc. 1 199.88 MG / 5.26 ML
00409-0181-01 Gemcitabine Hospira, Inc. 5 999.4 MG / 26.3 ML
16714-0909-01 Gemcitabine NorthStar Rx LLC 1 200 MG
25021-0234-10 gemcitabine Sagent Pharmaceuticals 1 200 MG / 5 ML
63323-0102-13 Gemcitabine Fresenius Kabi USA, LLC 1 200 MG / 5 ML
•••••-••••-•• Log in to view GEMCITABINE
GEMCITABINE
GEMCITABINE
Login to view 46 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

GEMCITABINE Pricing & Reimbursement

J9201 Private Payer Reimbursement
$3.50 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Gemcitabine 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9184 Avyxa Pharma Gemcitabine Injection, gemcitabine hydrochloride (avyxa), 200 mg
J9196 Accord Gemcitabine Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
J9198 Sun Pharma Gemcitabine Injection, gemcitabine hydrochloride, (infugem), 100 mg
J9201 Generic Code (Multiple Manufacturers) Gemcitabine Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

GEMCITABINE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Gemcitabine (J9201) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

GEMCITABINE Medically Unlikely Edits (MUE)

The most billing units of J9201 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 200 mg.

Practitioner Office & Hospital Outpatient
20 units / day
= 4,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

GEMCITABINE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Breast Cancer Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer
Drug Class
Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is there an available Gemcitabine billing and coding guide?
We have not yet identified a manufacturer source of Gemcitabine billing and coding information.
Are there any available Gemcitabine patient assistance programs?
Our team did not identify a source for Gemcitabine patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Gemcitabine prescribing information?
GEMCITABINE prescribing information can be found at the link below: Visit Here →
Where can I find Gemcitabine side effect information?
Information regarding GEMCITABINE's side effects can be found at MedlinePlus Visit Here →
Does billing GEMCITABINE require JZ/JW wastage modifiers?
CMS has identified GEMCITABINE(J9201) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to GEMCITABINE.

J9184AVGEMSIInjection, gemcitabine hydrochloride (avyxa), 200 mgAvyxa PharmaAdded January 1, 2026J9196GEMCITABINEInjection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mgAccordAdded April 1, 2023J9171DOCETAXELInjection, docetaxel, 1 mgMultiple ManufacturersAdded January 1, 2010J9174BEIZRAYInjection, docetaxel (beizray), 1 mgZydus PharmaceuticalsAdded July 1, 2025J9232DocetaxelInjection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mgMultiple ManufacturersAdded July 1, 2026J9267PaclitaxelInjection, paclitaxel, 1 mgMultiple ManufacturersAdded January 1, 2015J9271KEYTRUDAInjection, pembrolizumab, 1 mgMerck Sharp & Dohme CorpAdded January 1, 2016J9277Keytruda QlexInjection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmphMerck Sharp & Dohme CorpAdded April 1, 2026J9172DOCIVYXInjection, docetaxel (docivyx), 1 mgAvyxa PharmaAdded January 1, 2024J8522XELODACapecitabine, oral, 50 mgMultiple ManufacturersAdded October 1, 2024